Edition:
United States

DexCom Inc (DXCM.O)

DXCM.O on Nasdaq

56.41USD
16 Jan 2018
Change (% chg)

-- (--)
Prev Close
$56.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,041,394
52-wk High
$86.74
52-wk Low
$42.62

Latest Key Developments (Source: Significant Developments)

DexCom Says Preliminary Q4 Revenue Was $218 Mln
Monday, 8 Jan 2018 04:05pm EST 

Jan 8 (Reuters) - DexCom Inc ::DEXCOM REPORTS RECORD PRELIMINARY, UNAUDITED REVENUE FOR THE FOURTH QUARTER AND FISCAL YEAR 2017 AND PROVIDES INITIAL 2018 OUTLOOK.SEES FY 2018 REVENUE ABOUT $830 MILLION TO $850 MILLION.SEES FY 2017 REVENUE ABOUT $715 MILLION.PRELIMINARY Q4 REVENUE $218 MILLION VERSUS I/B/E/S VIEW $212.6 MILLION .FY2017 REVENUE VIEW $710.2 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 REVENUE VIEW $854.6 MILLION -- THOMSON REUTERS I/B/E/S.Q4 REVENUE VIEW $212.7 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Dexcom announces development agreement with Lilly
Tuesday, 21 Nov 2017 10:33am EST 

Nov 21 (Reuters) - Dexcom Inc ::Dexcom announces development agreement with Lilly to integrate Dexcom CGM into connected diabetes ecosystem.Says ‍companies expect to combine Lilly's smart insulin delivery devices and Dexcom CGM.  Full Article

Dexcom Inc reports Q3 GAAP loss per share $0.02
Wednesday, 1 Nov 2017 04:01pm EDT 

Nov 1 (Reuters) - Dexcom Inc :Dexcom, inc. Reports record third quarter 2017 financial results.Q3 non-gaap loss per share $0.04.Q3 gaap loss per share $0.02.Q3 revenue $184.6 million versus i/b/e/s view $184.2 million.Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.  Full Article

‍Tandem Diabetes Care to provide all t:slim X2 insulin pump features approved in 2018 to users at no cost
Tuesday, 24 Oct 2017 04:30pm EDT 

Oct 24 (Reuters) - Tandem Diabetes Care Inc ::‍Tandem Diabetes Care to provide all t:slim x2 insulin pump features approved in 2018 to users at no cost, expands existing dexcom welcome offer for animas customers​.Tandem diabetes care inc - ‍tandem and Dexcom are now extending terms of their welcome programs for animas customers through march 31, 2018​.  Full Article

‍Janus Henderson reports 10.2 pct passive stake in Dexcom
Wednesday, 11 Oct 2017 06:08am EDT 

Oct 11 (Reuters) - ‍Janus Henderson Group PLC:‍Janus Henderson Group PLC reports a 10.2 percent passive stake in Dexcom Inc as of sept 30 - SEC filing​.  Full Article

Dexcom Q2 revenue $170.6 mln; names new CFO
Tuesday, 1 Aug 2017 04:01pm EDT 

Aug 1 (Reuters) - Dexcom Inc :Dexcom reports second quarter 2017 financial results.Q2 non-GAAP loss per share $0.16.Q2 GAAP earnings per share $0.03.Q2 revenue $170.6 million versus I/B/E/S view $166.3 million.Q2 earnings per share view $-0.22 -- Thomson Reuters I/B/E/S.Dexcom announced that Quentin Blackford has been appointed chief financial officer, expected to occur on September 1, 2017.  Full Article

Dexcom announces FDA approval of G5 mobile app for android devices
Wednesday, 7 Jun 2017 08:00am EDT 

June 7 (Reuters) - Dexcom Inc :Dexcom announces fda approval of g5 mobile app for android devices.Dexcom Inc - ‍food and drug administration (fda) approval of dexcom g5 mobile app for android devices​.  Full Article

Dexcom prices offering of $350 mln of 0.75% convertible senior notes
Monday, 8 May 2017 08:04pm EDT 

May 8 (Reuters) - Dexcom Inc :Prices offering of $350 million of 0.75% convertible senior notes.Pricing of its offering of $350 million aggregate principal amount of 0.75% convertible senior notes due 2022.Notes will be senior, unsecured obligations of dexcom, and will bear interest at a rate of 0.75% per year, payable semi-annually in arrears.  Full Article

Dexcom announces proposed offering of convertible senior notes
Monday, 8 May 2017 07:09am EDT 

May 8 (Reuters) - Dexcom Inc :Dexcom announces proposed offering of $300 million of convertible senior notes.Intends to offer $300 million aggregate principal amount of convertible senior notes due 2022.Notes will be senior, unsecured obligations of Dexcom, and interest will be payable semi-annually in arrears.Notes will mature on May 15, 2022.Expects to use net proceeds of offering of notes to repay $75 million of borrowings under its existing credit facility.  Full Article

Dexcom reports Q1 revenue $142.3 million
Tuesday, 2 May 2017 04:01pm EDT 

May 2 (Reuters) - Dexcom Inc :Dexcom, Inc. Reports first quarter 2017 financial results.Q1 GAAP loss per share $0.49.Q1 revenue $142.3 million versus I/B/E/S view $144.4 million.Q1 earnings per share view $-0.50 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-DexCom Says Preliminary Q4 Revenue Was $218 Mln

* DEXCOM REPORTS RECORD PRELIMINARY, UNAUDITED REVENUE FOR THE FOURTH QUARTER AND FISCAL YEAR 2017 AND PROVIDES INITIAL 2018 OUTLOOK